Prokaryotics
Dr. Pompliano is currently Operating Partner at Accelerator Life Science Partners, and has had a long and influential career in Infectious Disease Drug Discovery in a variety of roles, including VP at Merck, CSO at Revolution Medicines and Lodo Therapeutics, and entrepreneur at Third Rock Ventures.
This person is not in the org chart
This person is not in any offices
Prokaryotics
Prokaryotics is a start-up biotechnology company resulting from licensing several novel antibiotic programs from Merck & Co., Inc. – by a team of former senior scientists at the company including the head of the Antimicrobial Early Discovery Unit, to optimize a number of Merck’s early-stage programs. Prokaryotics has negotiated worldwide rights to develop, manufacture and commercialize pre-clinical assets and programs targeting both Gram-negative and Gram-positive bacteria.